Literature DB >> 26907528

Dendritic Spine Pathology in Neurodegenerative Diseases.

Jochen Herms1,2,3, Mario M Dorostkar1.   

Abstract

Substantial progress has been made toward understanding the neuropathology, genetic origins, and epidemiology of neurodegenerative diseases, including Alzheimer's disease; tauopathies, such as frontotemporal dementia; α-synucleinopathies, such as Parkinson's disease or dementia with Lewy bodies; Huntington's disease; and amyotrophic lateral sclerosis with dementia, as well as prion diseases. Recent evidence has implicated dendritic spine dysfunction as an important substrate of the pathogenesis of dementia in these disorders. Dendritic spines are specialized structures, extending from the neuronal processes, on which excitatory synaptic contacts are formed, and the loss of dendritic spines correlates with the loss of synaptic function. We review the literature that has implicated direct or indirect structural alterations at dendritic spines in the pathogenesis of major neurodegenerative diseases, focusing on those that lead to dementias such as Alzheimer's, Parkinson's, and Huntington's diseases, as well as frontotemporal dementia and prion diseases. We stress the importance of in vivo studies in animal models.

Entities:  

Keywords:  Alzheimer's disease; Huntington's disease; Parkinson's disease; dementia; synapse

Mesh:

Year:  2016        PMID: 26907528     DOI: 10.1146/annurev-pathol-012615-044216

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  81 in total

1.  Distinct Impacts of Fullerene on Cognitive Functions of Dementia vs. Non-dementia Mice.

Authors:  Yawen Wu; Runzi Wang; Yuexiang Wang; Jing Gao; Lina Feng; Zhuo Yang
Journal:  Neurotox Res       Date:  2019-06-20       Impact factor: 3.911

Review 2.  Spine dynamics in the brain, mental disorders and artificial neural networks.

Authors:  Haruo Kasai; Noam E Ziv; Hitoshi Okazaki; Sho Yagishita; Taro Toyoizumi
Journal:  Nat Rev Neurosci       Date:  2021-05-28       Impact factor: 34.870

3.  Lynx1 Limits Dendritic Spine Turnover in the Adult Visual Cortex.

Authors:  Mari Sajo; Graham Ellis-Davies; Hirofumi Morishita
Journal:  J Neurosci       Date:  2016-09-07       Impact factor: 6.167

Review 4.  Prion neurotoxicity.

Authors:  Nhat T T Le; Bei Wu; David A Harris
Journal:  Brain Pathol       Date:  2019-01-17       Impact factor: 6.508

5.  Serum- and glucocorticoid-inducible kinase 1 activity reduces dendritic spines in dorsal hippocampus.

Authors:  Emily E Steffke; Deniz Kirca; Michelle S Mazei-Robison; Alfred J Robison
Journal:  Neurosci Lett       Date:  2020-03-10       Impact factor: 3.046

6.  Cdk5 Contributes to Huntington's Disease Learning and Memory Deficits via Modulation of Brain Region-Specific Substrates.

Authors:  Elena Alvarez-Periel; Mar Puigdellívol; Verónica Brito; Florian Plattner; James A Bibb; Jordi Alberch; Silvia Ginés
Journal:  Mol Neurobiol       Date:  2017-12-29       Impact factor: 5.590

7.  Ketamine Regulates Phosphorylation of CRMP2 To Mediate Dendritic Spine Plasticity.

Authors:  Zhongqi Zhang; JiFeng Zhang; Jiong Li; Jiaqi Zhang; Li Chen; Yalan Li; Guoqing Guo
Journal:  J Mol Neurosci       Date:  2019-12-05       Impact factor: 3.444

Review 8.  Opioid and chemokine regulation of cortical synaptodendritic damage in HIV-associated neurocognitive disorders.

Authors:  Bradley Nash; Lindsay Festa; Chihyang Lin; Olimpia Meucci
Journal:  Brain Res       Date:  2019-08-26       Impact factor: 3.252

Review 9.  Identification of anti-prion drugs and targets using toxicity-based assays.

Authors:  Robert Cc Mercer; David A Harris
Journal:  Curr Opin Pharmacol       Date:  2019-01-23       Impact factor: 5.547

Review 10.  Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Authors:  Piotr Lewczuk; Peter Riederer; Sid E O'Bryant; Marcel M Verbeek; Bruno Dubois; Pieter Jelle Visser; Kurt A Jellinger; Sebastiaan Engelborghs; Alfredo Ramirez; Lucilla Parnetti; Clifford R Jack; Charlotte E Teunissen; Harald Hampel; Alberto Lleó; Frank Jessen; Lidia Glodzik; Mony J de Leon; Anne M Fagan; José Luis Molinuevo; Willemijn J Jansen; Bengt Winblad; Leslie M Shaw; Ulf Andreasson; Markus Otto; Brit Mollenhauer; Jens Wiltfang; Martin R Turner; Inga Zerr; Ron Handels; Alexander G Thompson; Gunilla Johansson; Natalia Ermann; John Q Trojanowski; Ilker Karaca; Holger Wagner; Patrick Oeckl; Linda van Waalwijk van Doorn; Maria Bjerke; Dimitrios Kapogiannis; H Bea Kuiperij; Lucia Farotti; Yi Li; Brian A Gordon; Stéphane Epelbaum; Stephanie J B Vos; Catharina J M Klijn; William E Van Nostrand; Carolina Minguillon; Matthias Schmitz; Carla Gallo; Andrea Lopez Mato; Florence Thibaut; Simone Lista; Daniel Alcolea; Henrik Zetterberg; Kaj Blennow; Johannes Kornhuber
Journal:  World J Biol Psychiatry       Date:  2017-10-27       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.